Skip Navigation

Dietary Supplement Use in Women: Current Status and Future Directions Agenda

Skip sharing on social media links

Monday, January 28, 2002

8:15-8:30 Convocation and Welcome
8:30-8:45 Keynote Address: Dietary Supplements and Women's Health

Plenary Session I: Overview of Dietary Supplements

Focus: An overview of the universe of dietary supplements currently marketed to women, possible justification based on national survey data, and history of use both in the U.S. and internationally
8:45-9:00 Introduction: Conference Coverage
9:00-9:20 Current Evidence of Use of Dietary Supplements by Women: Overview of Data from the National Nutrition Monitoring System
9:20-9:40 Experiences in Implementation of Supplementation Programs: International Perspective
9:40-10:00 Herbals/Botanical Supplements: Indications and Clinical Concerns
10:00-10:20 Traditional Use and Current Status of Phytotherapy Use by Women: Contrasts and Parallels from an International Perspective
10:30-10:50 BREAK

Plenary Session II: Monitoring

Focus: Identification of processes planned and in place to provide data about who uses dietary supplements, which ones, why, and analytical issues related to database generation
Session Chair: Johanna Dwyer, USDA
10:50-11:10 Current Usage Patterns: Who, What, Why, How Much?
11:10-11:30 National Nutrition Monitoring: How Can We Develop Evidence Base to Inform National Policy Decisions about Supplement Use: Dietary Essential Nutrients
11:30-11:50 Regulatory Perspective, FDA: Case Study for Implementation of Intervention; Fortification and Impact on Intake Including Supplement Use by Women During the Reproductive Years
11:50-12:10 Industry-based Data: Who and What? Usage Patterns by Women; Data on Supplement Composition
12:10-12:30 General Discussion
12:30-1:30 LUNCH
1:30-3:00 Panel Session I: Monitoring and Data Needs
Panel Questions:
  1. What are the critical gaps in our knowledge about patterns of use of dietary supplements by women? Across developmental states/stages?
  2. What are strengths and weaknesses of current surveillance systems in terms of monitoring use patterns across the diverse range of ethnic, demographic, and developmental and physiological/age groups?
  3. What are the key methodological issues to be addressed with respect to surveillance of dietary essentials, herbals/botanicals, and other bioactive ingredients as dietary supplements?
  4. What are the five essential research questions that need to be addressed in terms of monitoring dietary supplement use?
3:00-3:30 BREAK

Plenary Session III: Developmental Physiology

Focus: Discussion of specific needs of women at critical periods of physiology and in different demographic and/or geographic settings. Identification of factors, e.g., bioavailability, to be considered in the safety evaluation of dietary supplements to be used by women with particular emphasis on different stages of development and physiological conditions.
Session Chair: Janet King, USDA Western Human Nutrition Center/University of California-Davis
3:30-3:50 Adolescence
3:50-4:10 Reproductive Health Issues
4:10-4:30 Pregnancy/Lactation
4:30-4:50 Peri/Post-Menopause
4:50-5:10 General Discussion

Tuesday, January 29, 2002

8:30-10:00 Panel Session II: Developmental Physiology
Panel Questions:
  1. What are the three core research questions for each stage of physiological development discussed during the plenary session?
  2. Are there differences in scientific issues dependent on geographical, ethnic or demographic settings?
    • General context: i.e., women irrespective of setting
    • U.S. perspective
    • International context
  3. What are the issues that might exist with respect to different classes of dietary supplements and physiological state?
10:00-10:30 BREAK

Plenary Session IV: Case Studies

Focus: Demonstrations of the interaction between science, policy and consumer practices using well-characterized examples of dietary supplements and their use, advocacy and safety across developmental periods
Session Chair: Anne Looker, National Center for Health Statistics, CDC
10:50-11:10 Calcium
11:10-11:30 Iron
11:30-11:50 Folic Acid
11:50-12:10 Phytoestrogens
12:10-12:30 General Discussion
12:30-1:30 LUNCH

Plenary Session V: Factors Influencing the Decision to Use Dietary Supplements

Focus: Review of factors that influence one's exposure to and decisions to use dietary supplements
Session Chair: Mark Conner, University of Leeds
1:30-1:50 Environmental Influences: Factors Influencing the Decision to Use Dietary Supplements
1:50-2:10 Dietary Supplement Use in the Context of Health Disparities: Cultural/Ethnic/Demographic Determinants of Use
2:10-2:30 The Role of the Media
2:30-2:50 General Discussion
2:50-3:20 BREAK
3:20-4:50 Panel Session III: Coverage plenary sessions 4 and 5
Core Questions:
  1. Based on the case studies presented, what are the strengths and weaknesses of our current system for translation of science into practice?
  2. What are the obstacles to implementation of evidence based practice domestically? Internationally?
  3. Social/Cultural and Behavior Factors Associated with Patterns of use in women: How can we get input from and to consumers about dietary supplement use? What factors need to be evaluated to determine how attitudes and behaviors are formed relative to the use of dietary supplements?
4:50-5:10 Summary and Closing Remarks
Last Reviewed: 11/30/2012
Vision National Institutes of Health Home BOND National Institues of Health Home Home Storz Lab: Section on Environmental Gene Regulation Home Machner Lab: Unit on Microbial Pathogenesis Home Division of Intramural Population Health Research Home Bonifacino Lab: Section on Intracellular Protein Trafficking Home Lilly Lab: Section on Gamete Development Home Lippincott-Schwartz Lab: Section on Organelle Biology